Cervical cancer: open trials in China

159 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07919431
Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer
Research · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2026-11-05
NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Trial Treatment · Phase 1/2 · Genmab
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing · Jilin Cancer Hospital, Changchun · Hunan Cancer Hospital - Phase 1, Changsha · Hunan Cancer Hospital - Thoracic Medicine Dept II, Changsha · Obstetrics & Gynecology Hospital of Fudan University, Chengdu · Chongqing University Cancer Hospital, Chongqing · Fujian Cancer Hospital, Fujian · Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong · Zhejiang Cancer Hospital, Hangzhou · Second Affiliated Hospital of Zhengzhou University, Henan · Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei · Jiangxi maternal and child health hospital, Nanchang · Shanghai East Hospital, Shanghai · Fudan University Shanghai Cancer Center- Phase 1, Shanghai · Fudan University Shanghai Cancer Center - Gynecologic Oncology, Shanghai · Sichuan Cancer Hospital, Shanghai · Second Hospital of Shanxi Medical University, Shanxi · Shanxi Cancer Hospital, Shanxi · Liaoning Cancer Hospital & Institute, Shengyang · Tianjin Cancer Hospital, Tianjin
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Beijing Cancer Hospital, Beijing · Sun Yat-sen University Cancer Center, Guangzhou · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Beijing Cancer Hospital - Oncology Department, Beijing · Peking University First Hospital - Oncology Department, Beijing · Hunan Cancer Hospital - Oncology Department, Changsha · Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou · Zhongshan Hospital,Fudan University, Shanghai · Fudan University Shanghai Cancer Center - Oncology Department, Shanghai
Registry updated 2026-11-04
NCT06641635
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Trial Treatment · Phase 3 · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2026-11-03
NCT07911423
Immunotherapy in Neuroendocrine Carcinoma of the Cervix
Research · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2026-11-02
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · DualityBio Inc.
CHN23-0, Beijing · CHN02-0, Beijing · CHN13-0, Beijing · CHN11-0, Changsha · CHN24-0, Chengdu · CHN17-0, Dongguan · CHN06-0, Henan · CHN04-0, Hubei · CHN01-0, Shanghai · CHN04-0, Shanghai · CHN35-0, Shenyang · CHN34-0, Wuhan · CHN26-0, Wuhan · CHN25-0, Xi'an · CHN12-0, Xinxiang · CHN16-0, Xuzhou
Registry updated 2026-10-29
NCT07904182
Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
Trial Treatment · Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Registry updated 2026-10-29
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
West China Hospital，Sichuan University, Chengdu · Sun Yat-sen University Cancer Center, Guangzhou
Registry updated 2026-10-26
NCT07895212
Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy
Trial Treatment · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
Registry updated 2026-10-26
NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · DualityBio Inc.
Baoding · Beijing · Beijing · Beijing · Changchun · Changchun · Changsha · Changsha · Chengdu · Chengdu · Chengdu · Chengdu · Chongqing · Chongqing · Chongqing · Chongqing · Fuzhou · Ganzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Hangzhou · Hangzhou · Hangzhou · Hangzhou · Hangzhou · Harbin · Hefei · Jinan · Jinan · Linyi · Linyi · Luoyang · Nanchang · Nanchang · Nanjing · Nanjing · Nanjing · Nanning · Shanghai · Shanghai · Shanghai · Shenyang · Shenyang · Taizhou · Tianjin · Tianjin · Tianjin · Wuhan · Wuhan · Xi’an · Xinxiang · Zhengzhou · Zhengzhou
Registry updated 2026-10-21
NCT07879339
Multi-omics Study of Cervical Neuroendocrine Carcinoma
Research · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2026-10-16
NCT07876154
Iparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
Trial Treatment · Phase 2 · Xijing Hospital
The First Affiliated Hospital of Airforce Medical University, Xi'an
Registry updated 2026-10-15
NCT07202364
A Study of YL202 in Patients With Advanced Solid Tumors
Trial Treatment · Phase 2 · MediLink Therapeutics (Suzhou) Co., Ltd.
Hunan Provincial Tumor Hospital, Changsha
Registry updated 2026-10-14
NCT06993844
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Ensem Therapeutics
Beijing Luhe Hospital, Capital Medical University, Beijing · Fujian Cancer Hospital, Fuzhou · Sun Yat-sen University Cancer Center, Guangzhou · Shandong Cancer Hospital&Institute, Shandong · Fudan University Shanghai Cancer Hospital, Shanghai
Registry updated 2026-10-13
NCT07860203
Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery
Trial Treatment · Catherin Zhang
Huai'an Second People's Hospital, Huai'an
Registry updated 2026-10-06
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Beijing · Changde · Changsha · Chengdu · Chongqing · Fuzhou · Ganzhou · Guangzhou · Hangzhou · Harbin · Kunming · Lanzhou · Linyi · Luzhou · Nanchang · Shandong · Shanghai · Shenyang · Shenzhen · Tianjin · Wuhan · Xi'an · Yibin · Yinchuan · Zhengzhou · Zhuzhou
Registry updated 2026-09-30
NCT06714084
CNCMT：a Multi-center, Prospective, Single-arm Study
Trial Treatment · Hubei Cancer Hospital
Hubei Cancer Hospital, Wuhan
Registry updated 2026-09-18
NCT05798819
A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
Trial Treatment · Phase 3 · Guangzhou Gloria Biosciences Co., Ltd.
Fudan University Shanghai Cancer Hospital, Shanghai
Registry updated 2026-09-16
NCT07584161
MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
Trial Treatment · Xiaorong Hou
Peking Union Medical College Hospital, Beijing
Registry updated 2026-09-16
NCT06535607
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · AstraZeneca
Anyang · Beijing · Bengbu · Changchun · Changsha · Chengdu · Chongqing · Dongguan · Fuzhou · Guangzhou · Hangzhou · Harbin · Hefei · Jining · Kunming · Nanchang · Nanjing · Nanning · Shandong · Shanghai · Shenyang · Tianjin · Wuhan · Wuhou District · Zhengzhou
Registry updated 2026-09-11
NCT07811375
Perioperative Adebrelimab for Locally Advanced Cervical Cancer
Trial Treatment · Phase 2 · Anhui Provincial Hospital
Anhui Province Hospital, Hefei
Registry updated 2026-09-10
NCT07253194
Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
Trial Treatment · Lu Chao
Zhejiang Cancer Hospital, Hangzhou
Registry updated 2026-09-02
NCT07797153
JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer
Trial Treatment · Phase 3 · Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Sun Yat-sen University Cancer Center, Guangzhou · Affiliated Cancer Hospital of Fudan University, Shanghai
Registry updated 2026-09-01
NCT07776821
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
Trial Treatment · Phase 4 · Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital, Tianjin · Tianjin Cancer Hospital Airport Branch, Tianjin
Registry updated 2026-08-25

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error